UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 362

Sortiert nach

Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy

Annals of oncology, 2015-09, Vol.26 (9), p.1948-1953

2015

Volltextzugriff (PDF)

Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41

Journal of Virology, 2001-11, Vol.75 (22), p.10892-10905

2001

Volltextzugriff (PDF)

Neutralization Synergy of Human Immunodeficiency Virus Type 1 Primary Isolates by Cocktails of Broadly Neutralizing Antibodies

Journal of Virology, 2001-12, Vol.75 (24), p.12198-12208

2001

Volltextzugriff (PDF)

Therapeutic potential of neutralizing antibodies in the treatment of HIV-1 infection

Journal of antimicrobial chemotherapy, 2003-04, Vol.51 (4), p.757-759

2003

Volltextzugriff (PDF)

Membrane-Anchored Peptide Inhibits Human Immunodeficiency Virus Entry

Journal of Virology, 2001-03, Vol.75 (6), p.3038-3042

2001

Volltextzugriff (PDF)

A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1

AIDS (London), 2002-01, Vol.16 (2), p.227-233

2002

Volltextzugriff (PDF)

Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies

Journal of Virology, 2004-12, Vol.78 (23), p.13232-13252

2004

Volltextzugriff (PDF)

Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies

Science (American Association for the Advancement of Science), 2005-06, Vol.308 (5730), p.1906-1908

2005

Volltextzugriff (PDF)

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

Nature medicine, 2005-06, Vol.11 (6), p.615-622

2005

Volltextzugriff (PDF)

Preparation of granulocyte concentrates by apheresis

Vox sanguinis, 2010-05, Vol.98 (4), p.567-575

2010

Volltextzugriff (PDF)

Anti-Human Immunodeficiency Virus Type 1 (HIV-1) Antibodies 2F5 and 4E10 Require Surprisingly Few Crucial Residues in the Membrane-Proximal External Region of Glycoprotein gp41 To Neutralize HIV-1

Journal of Virology, 2005-01, Vol.79 (2), p.1252-1261

2005

Volltextzugriff (PDF)

Red cell antibodies in frequently transfused patients with myelodysplastic syndrome

Annals of hematology, 2001-06, Vol.80 (6), p.330-333

2001

Volltextzugriff (PDF)

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

Nature medicine, 2000-02, Vol.6 (2), p.207-210

2000

Volltextzugriff (PDF)

A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge

Equine veterinary journal, 2001-11, Vol.33 (7), p.630-636

2001

Volltextzugriff (PDF)

A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1

AIDS research and human retroviruses, 2001-12, Vol.17 (18), p.1757-1765

2001

Volltextzugriff (PDF)

Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies

Journal of Virology, 1999-05, Vol.73 (5), p.4009-4018

1999

Volltextzugriff (PDF)

Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P-selectin

Transfusion (Philadelphia, Pa.), 1998-01, Vol.38 (1), p.24-30

1998

Volltextzugriff (PDF)

Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures

The FASEB journal, 2007-06, Vol.21 (8), p.1655-1664

2007

Volltextzugriff (PDF)

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

Nature medicine, 2000-02, Vol.6 (2), p.200-206

2000

Volltextzugriff (PDF)

Exposure of the Membrane-Proximal External Region of HIV-1 gp41 in the Course of HIV-1 Envelope Glycoprotein-Mediated Fusion

Biochemistry (Easton), 2007-02, Vol.46 (5), p.1398-1401

2007

Volltextzugriff (PDF)

Characterization of Human Class-Switched Polymeric (Immunoglobulin M [IgM] and IgA) Anti-Human Immunodeficiency Virus Type 1 Antibodies 2F5 and 2G12

Journal of Virology, 2003-04, Vol.77 (7), p.4095-4103

2003

Volltextzugriff (PDF)

Cloning of a family of serine protease genes from the cat flea Ctenocephalides felis

Insect molecular biology, 1999-02, Vol.8 (1), p.11-22

1999

Volltextzugriff (PDF)

Germans learn to bet on biotech

Nature (London), 1996-10, Vol.383 (6602), p.744-744

Stiegler, Gabor

1996

Volltextzugriff (PDF)

Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation

Transplantation, 2005-04, Vol.79 (7), p.807

2005

Volltextzugriff (PDF)

Bacterial Contamination of Blood Components

Vox sanguinis, 2000, Vol.78 (1), p.59-67

2000

Volltextzugriff (PDF)

1 – 25 von 362

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(308)
Mit Volltextzugriff
(311)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(193)
Life Sciences & Biomedicine
(126)
Humans
(125)
Biological And Medical Sciences
(73)
Female
(65)
Male
(58)
Medical Sciences
(57)
Physical Sciences
(51)
Physics
(51)
Adult
(49)
Middle Aged
(39)
Animals
(36)
Technology
(35)
Fundamental And Applied Biological Sciences. Psychology
(32)
Physics, Particles & Fields
(29)
Virology
(28)
Hiv-1 - Immunology
(26)
Antibodies, Monoclonal - Immunology
(23)
Human Immunodeficiency Virus 1
(23)
Neutralization Tests
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy

Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41

Neutralization Synergy of Human Immunodeficiency Virus Type 1 Primary Isolates by Cocktails of Broadly Neutralizing Antibodies

Therapeutic potential of neutralizing antibodies in the treatment of HIV-1 infection

Membrane-Anchored Peptide Inhibits Human Immunodeficiency Virus Entry

A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1

Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies

Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

Preparation of granulocyte concentrates by apheresis

Anti-Human Immunodeficiency Virus Type 1 (HIV-1) Antibodies 2F5 and 4E10 Require Surprisingly Few Crucial Residues in the Membrane-Proximal External Region of Glycoprotein gp41 To Neutralize HIV-1

Red cell antibodies in frequently transfused patients with myelodysplastic syndrome

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge

A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1

Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies

Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P-selectin

Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

Exposure of the Membrane-Proximal External Region of HIV-1 gp41 in the Course of HIV-1 Envelope Glycoprotein-Mediated Fusion

Characterization of Human Class-Switched Polymeric (Immunoglobulin M [IgM] and IgA) Anti-Human Immunodeficiency Virus Type 1 Antibodies 2F5 and 2G12

Cloning of a family of serine protease genes from the cat flea Ctenocephalides felis

Germans learn to bet on biotech

Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation

Bacterial Contamination of Blood Components

Suchergebnisse filtern